MYX

3.87%

$4.47 mayne pharma group limited

MYX new all time highs, if and when possible?, page-356

First 356 Last

Share
Profile

Follow
Chartsshout

6,899 Posts.

431

26/07/18

14:02

Post #: 34575920
Share

Originally posted by Chartsshout ↑

Looks like bull is holding its fire after positioning itself above 90.
Waiting for numbers on 24th Aug 18.
Looks like if they are OK as expected
we go through one dollar then if not before.
If all keeps going well,
under that scenario MYX
may hit all time new highs by August 2019 end rather than my previous likely price projection of above 2 dollars by Dec 2019 end.
Here are few points from Feb 2018 presentation.
Have a good read to refresh yourself as a long term investor.

Some interesting reading from 1H 2018 FINNCL YR report.

23 February 2018 MAYNE PHARMA REPORTS 2018 HALF YEAR PERFORMANCE • Revenue of $243.3m, a decrease of 17% on 1HFY17 • Adjusted EBITDA of $70.2m, down 36% on 1HFY17 • Reported EBITDA of $23.0m, down 82% on 1HFY17 • Reported net loss after tax of $174.2m driven by asset impairments, abnormal Doryx® returns and stock obsolescence, restructuring expenses and restatement of deferred tax assets and liabilities following the US tax rate change • Positive operating cash flow of $48.0m • Significantly improved trading in 2QFY18 which has strengthened further into January • US generic market appears to be stabilising and competitor disruptions creating opportunities • Expanded Specialty Brands team to 120 sales representatives to drive growth of Fabior®, Sorilux® and Doryx® MPC • New Greenville manufacturing facility to commence production in the next month, enhancing internal capabilities and improving margins for third party transferred products • Business positioned for a stronger second half driven by stabilising generic market, new product launches, expanded dermatology sales team, contract services committed business pipeline and cost benefits from the restructure.

The pipeline is expected to drive growth in future periods driven by key launches including generic NuvaRing® and our patented formulation of SUBA®- Itraconazole as an anti-fungal in the United States.”

Summary of results1 Change on pcp $m 1HFY18 1HFY17 pcp $m % Revenue 243.3 294.8 (51.5) (17%) Gross profit 95.9 171.2 (75.3) (44%) GM% 39% 58% EBITDA – adjusted2 70.2 109.9 (39.7) (36%) EBITDA – reported 23.0 129.2 (106.2) (82%) Net income / (loss) - adjusted 16.0 59.5 (43.5) (73%) Net income / (loss) - reported (174.2) 72.7 (256.9) Nm

Adjusting for these one-off items, group revenue would have been down 13% on pcp, gross profit margin would have been 50% and adjusted EBITDA was $70.2m down 36%.

(Oh dear. These margins are higher than CSL)
What do you want to say here..

The Company remains committed to growing its core business segments by investing in both internal and external product development opportunities. During the half, the Company invested $63m in its facilities and product pipeline with $40m primarily spent on the expansion programs at Greenville and Salisbury, in addition to $23m on research and development. The solid oral dose manufacturing facility in Greenville is almost complete and the Company is in the process of transferring in house 8 acquired Teva products which are currently outsourced. This will increase the economic benefit that flows to Mayne Pharma as well as introduce downstream commercial manufacturing services to Metrics Contract Services

Expand

What will happen to MYX stock price when
MYX goes back to the index ASX 300 ASX 200. ETC.
Rememebr at the moment
MYX is a penny stock
and many fundies cant buy
it .
When when weightings of the index are redone
and MYX goes bcak to the index,
many fund managers are and will be
forced to buy MYX back.
We are heading fast towards discovery of fair price
of MYX stock it appears.

MYX Price at posting: 96.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 1 more message in this thread...

First 356 Last

Add MYX (ASX) to my watchlist

(20min delay)
Last $4.47		Change -0.180(3.87%)		Mkt cap ! $380.2M

Open	High	Low	Value	Volume
$4.62	$4.62	$4.45	$780.9K	172.9K

Buyers (Bids)

No.	Vol.	Price($)
1	422	$4.46

Sellers (Offers)

Price($)	Vol.	No.
$4.49	198	1

View Market Depth

No.	Vol.	Price($)
1	422	4.460
3	10310	4.450
3	1411	4.440
2	1411	4.430
2	1411	4.420

Price($)	Vol.	No.
4.490	198	1
4.500	198	1
4.510	1411	2
4.520	1411	2
4.530	1411	2

Last trade - 16.10pm 17/06/2024 (20 minute delay)


Last $4.46		Change -0.180 ( 3.33 %)
Open	High	Low	Volume
$4.60	$4.60	$4.45	27159
Last updated 15.59pm 17/06/2024 ?

MYX (ASX) Chart

MYX new all time highs, if and when possible?, page-356

Featured News

From the Floor question: "Is lithium dead?"

Construction commences on the Nobles Gold Processing Facility

ASX Market Update: Shares slip with energy and IT in drag mode | 17 June, 2024

RAU all set to samba in Brazil rare earths space off successful IPO launchpad

MiningNews Select Conference: Inflation and global shifts pose funding challenges for Aus miners

Buyers (Bids)

Sellers (Offers)

Featured News

MYX new all time highs, if and when possible?, page-356

Featured News

Top Stories

From the Floor question: "Is lithium dead?"

Construction commences on the Nobles Gold Processing Facility

ASX Market Update: Shares slip with energy and IT in drag mode | 17 June, 2024

RAU all set to samba in Brazil rare earths space off successful IPO launchpad

MiningNews Select Conference: Inflation and global shifts pose funding challenges for Aus miners

Buyers (Bids)

Sellers (Offers)

Featured News